JP Morgan initiated coverage on Bytes Technology Group with an 'underweight' rating due to its limited exposure to AI monetisation, particularly hardware contributing less than 10% of gross profit. The bank prefers Computacenter as its top pick in the European value-added reseller (VAR) sector because of its stronger AI-related business and hyperscale capital expenditure focus. This downgrade reflects concerns about Bytes' ability to meet consensus earnings estimates amid changes in vendor incentives and the risk of vendor disintermediation, which could pressure intermediaries lacking strategic value. Investors should watch how Bytes adapts to these challenges and whether it can enhance its AI capabilities to remain competitive.
Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...
Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...
AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...
President Trump signed a proclamation on October 23, 2026, reshuffling which Canadian goods face his 50% tariffs, removing items like plywood and packing crates but adding others such as carpets and vinyl flooring. The broad tariffs on about $20 bill...
Injective CEO Eric Chen met with officials from the White House, SEC, and CFTC in October 2026 to discuss advancing regulated onchain finance and tokenization of real-world assets (RWAs) in the US. Injective, registered as a transfer agent by the SEC...
